We are updating our Privacy Policy and Terms and Conditions to help you clearly understand how your personal information is collected, stored and managed. Learn More
Menu Back toBayesian-Application-in-Samll-Sized-Clinical-Trials

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

Bayesian Application in Small-Sized Clinical Trials

    Session Chair(s)
      Fei  Wang

      Fei Wang

      • Senior Manager, Biostatistics
      • Amgen, United States
    The use of historical data demonstrates value and efficiency in designing clinical trials, especially in nonconfirmatory trials. This session presents an overview of theoretical framework, case studies in exploratory situations, and future directions.
    Learning Objective : Describe the use of historical information on controls in rare disease and pediatric settings; Discuss the challenges and concerns in design of confirmatory trials; Analyze industry and regulatory point of view and potentially pilot solutions.
      James  Travis, PhD

      Incorporating Adult Study Data into Pediatric Clinical Trials: Is Bayesian Borrowing the Solution?

      James Travis, PhD

      • Staff Fellow, OB, OTS, CDER
      • FDA, United States
      Sharon-Lise  Normand

      Approaches to Medical Device Evaluation Using Real-World Evidence

      Sharon-Lise Normand

      • Professor of Health Care Policy (Biostatistics)
      • Harvard Medical School, United States
      Amy  Xia, PhD

      Bayesian Applications for Extrapolation from Adult to Pediatric Data

      Amy Xia, PhD

      • Executive Director, Biostatistics
      • Amgen Inc., United States